HealthcareEtcembly and University of Surrey Launch Pioneering Study to Unlock Next-Generation Cancer Treatments From Survivors
British techbio innovator Etcembly is teaming up with researchers and clinicians from the University of Surrey to launch a groundbreaking new study that could transform the future of cancer treatment. By analysing the immune cells of cancer survivors, this research is set to reveal untapped targets that could deliver the next generation of immunotherapies. “By studying people who are surviving cancer, we can identify targets that have already proven to be effective, giving us a blueprint to develop a...